Successful pregnancy and delivery in a patient with Parkinson's disease under pramipexole treatment
نویسندگان
چکیده
[1] Urita Y, Nishino M, Koyama H, Kondo E, Naruki Y, Otsuka S. Esophageal anisakiasis accompanied by reflux esophagitis. Intern Med 1997;36:890-3. [2] Hubert B, Belvèze H, Bacou J. L’anisakiase en France (1985–1987). BEH 1987;48:189-91. [3] Yera H, Estran C, Delaunay P, Gari-Toussaint M, Dupouy-Camet J, Marty P. because of the rarity of this condition. Accordingly, antiparkinsonian drug treatment during pregnancy, potential teratogenicity of drugs and the effect of pregnancy on the course of the disease wait to be better answered [1]. Most of the reported cases consisted of retrospective ques-
منابع مشابه
Successful pregnancy and delivery in a patient with Parkinson's disease under pramipexole treatment.
The clinical experience on the management of pregnancy in idiopathic Parkinson’s disease (PD) is limited with case reports because of the rarity of this condition. Accordingly, antiparkinsonian drug treatment during pregnancy, potential teratogenicity of drugs and the effect of pregnancy on the course of the disease wait to be better answered [1]. Most of the reported cases consisted of retrosp...
متن کاملPatient considerations in early management of Parkinson’s disease: focus on extended-release pramipexole
This article reviews the role of an extended-release formulation of pramipexole in the treatment of Parkinson's disease at an early stage. Pramipexole is a nonergot D(2)/D(3) synthetic aminobenzothiazole derivative that is effective as monotherapy in early disease and as an adjunct to levodopa in patients with motor fluctuations. Although levodopa is the current "gold standard" for treatment of...
متن کاملCost effectiveness of pramipexole in Parkinson's disease in the US.
OBJECTIVE Pramipexole was recently approved in the US for treatment of the symptoms of idiopathic Parkinson's disease (PD). Although pramipexole has been found to be safe and efficacious when compared with placebo, little data are yet available on its cost effectiveness when compared with baseline treatment. The aim of this study was to estimate the costs and cost effectiveness (cost utility) o...
متن کاملRole of pramipexole in the management of Parkinson's disease.
The non-ergot dopamine agonist pramipexole is currently indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease and for the treatment of moderate-to-severe primary restless legs syndrome. A new extended-release formulation of pramipexole has now also been launched in Europe and the US to improve ease of use, compliance and provide a more continuous therapeutic ef...
متن کاملEfficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study.
OBJECTIVES Pramipexole, a non-ergot dopamine D2/D3 receptor agonist, was investigated as an add on drug in advanced parkinsonian patients with motor fluctuations to assess efficacy, safety, and tolerance. METHODS Seventy eight patients of either sex with advanced Parkinson's disease and treatment complications such as motor fluctuations were enrolled into a double blind, placebo controlled, r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2014